United Laboratories (ULIHF) 0.3690 $ULIHF
United Laboratories Inc. and Debiopharm International SA Announce the Launch of Pamorelin® LA in the Philippines
PR Newswire Europe - Mon Dec 07, 2:29AM CST
MANDALUYONG, Philippines and LAUSANNE, Switzerland, December 7, 2015 /PRNewswire/ --
Investigation Report on China's Sodium Hyaluronate Market 2015
PR Newswire Europe - Fri Sep 04, 6:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dvzsqg/investigation [http://www.researchandmarkets.com/research/dvzsqg/investigation]) has announced the addition of the "Investigation Report on China's Sodium Hyaluronate Market, 2010-2019" [http://www.researchandmarkets.com/research/dvzsqg/investigation] report to their offering.
Investigation Report on China's Sodium Hyaluronate Market, 2010-2019
M2 - Fri Sep 04, 4:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zpkc4n/investigation) has announced the addition of the "Investigation Report on China's Sodium Hyaluronate Market, 2010-2019" report to their offering. Sodium hyaluronate is a long-chain polymer containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. As a major ingredient of synovial fluid and cartilage matrix, sodium hyaluronate can lubricate the joint, protect cartilage of the joint, improve joint contracture and pathological articular fluid. Sodium hyaluronate eye drop is used for the treatment of dry eyes and mechanical lesion to corneal endothelium while sodium hyaluronate injection is used as a joint function-improving agent for intra-articular injection on osteoarthropathy patients. Currently, only sodium hyaluronate injection and eye drop are available in the market. The raw materials of sodium hyaluronate can be classified into pharmaceutical grade, external grade and edible grade. Currently, hyaluronate is mainly used as the raw material of artificial synovial fluid and eye drops after eye surgery which together brought in a global sales value of USD 700-800 million. This figure is estimated to reach up to USD 3 billion if its cosmetics are counted too. In the middle of 1990s, preparations of sodium hyaluronate began to be used in the clinic in China, achieving good efficacy in ophthalmology, orthopaedics and surgery. Sodium hyaluronate develops fast after entering China, annual sales value rising from less than CNY 100 million in 2005 to CNY 290 million in 2014 and CAGR during this period reaching 18.61%. Sodium hyaluronate enjoys a vast demand in China. Seikagaku Corporation (Japan), United Laboratories, Bausch & Lomb, Santen Pharmaceutical Co., Ltd (Japan), Shanghai Jingfeng Pharmaceutical Co., Ltd and URSAPHARM Arzneimittel GmbH Co.KG (GE) all take up certain shares in the market, among of which Seikagaku Corporation (Japan) has the largest market share of 29% for sales value in 2014. Over the last decade, the demand for sodium hyaluronate in the area of health has kept increasing. With the ever-growing demand of life quality and the rapid aging of the urban population, senile diseases like cataract and osteoarthritis, the market size of sodium hyaluronate will continue to expand in China. Companies Mentioned - United Laboratories - Bausch & Lomb - Shanghai Jingfeng Pharmaceutical Co., Ltd - Shanghai Haohai Biological Technology Co., Ltd - Santen Pharmaceutical Co., Ltd (Japan) For more information visit http://www.researchandmarkets.com/research/zp...estigation
Investigation Report on China's Adefovir Market: 2010-2014 & 2015-2019
PR Newswire Europe - Fri Aug 07, 7:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nzj6mr/investigation [http://www.researchandmarkets.com/research/nzj6mr/investigation]) has announced the addition of the "Investigation Report on China's Adefovir Market, 2010-2019" [http://www.researchandmarkets.com/research/nzj6mr/investigation] report to their offering.
GILD: 81.05 (-7.50), GSK: 44.16 (+0.12)
Azithromycin Market & Polypeptide Drug Industry - Global Research Reports
PR Newswire - Wed Apr 01, 9:00AM CDT
LifeScienceIndustryResearch.com announces 2015 Market Research Report on Global Azithromycin Industry and 2015 Deep Research Report on Global Polypeptide Drug Industry reports added to Pharmaceutical category in its database.
Hartell Announces New PlenumPlus Commercial Grade Condensate Pump at the AHR Show in Chicago
PRWeb - Mon Jan 26, 11:08AM CST
Hartell, a brand of Accudyne Industries, today announced a new version of the PlenumPlus™ Commercial Grade condensate pump that's used to remove condensate formed in venting and air ducts in the plenum spaces of office buildings, manufacturing facilities, schools, hospitals, or any other commercial space. The new condensate pump will be on display in booth #4023 at the AHR Show this week at McCormick Place in Chicago.
Global Recombinant Human Insulin Industry Report 2015
M2 - Fri Jan 09, 6:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/mmtppx/global) has announced the addition of the "Global Recombinant Human Insulin Industry Report 2015" report to their offering. The report provides an overview of the industry including definitions, classifications, applications and industry chain structure. The Recombinant Human Insulin market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Recombinant Human Insulin industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on the Recombinant Human Insulin industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Recombinant Human Insulin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Recombinant Human Insulin Industry Overview - Recombinant Human Insulin International and China Market Analysis - Recombinant Human Insulin Technical Data and Manufacturing Plants Analysis - Recombinant Human Insulin Major Countries Import Export Consumption - Recombinant Human Insulin Manufacturing Process and Cost Structure - 2009-2014 Recombinant Human Insulin Productions Supply Sales Demand Market Status and Forecast - Recombinant Human Insulin Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Recombinant Human Insulin Marketing Channels Analysis - Recombinant Human Insulin Industry Development Trend - Recombinant Human Insulin Industry Development Proposals - Recombinant Human Insulin New Project Investment Feasibility Analysis - Global and China Recombinant Human Insulin Industry Research Conclusions Companies Mentioned - Bioton - Dongbao - Eli Lilly - Novo Nordisk - United Laboratories (TUL) For more information visit http://www.researchandmarkets.com/research/mmtppx/global
NVO: 56.29 (+0.99), LLY: 82.09 (+0.11)
Trans Global Group, Inc. Develops Strategic Partnership with Arrow Electronics Inc.
ACCESSWIRE - Mon Dec 08, 7:50AM CST
CORAL SPRINGS, FL / ACCESSWIRE / December 8, 2014 / Trans Global Group, Inc. (OTC PINK: TGGI) is pleased to announce the development of a strategic partnership with Arrow Electronics, Inc. traded on the NYSE: ARW, a Fortune 150 company with sales over $21 billion for fiscal 2013.
ARW: 66.16 (+0.41)
Global Insulin Industry Report 2014
M2 - Thu Nov 27, 9:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/vjd5kp/global_insulin) has announced the addition of the "Global Insulin Industry Report 2014" report to their offering. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The insulin market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Insulin industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on seven industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The insulin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Insulin Industry Overview - Insulin International and China Market Analysis - Insulin Manufacturing Plants Capacity Analysis - Major Countries Import Export Consumption - Insulin Manufacturing Process and Cost Structure - 2009-2014 Insulin Productions Supply Sales Demand Market Status and Forecast - Insulin Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Insulin Marketing Channels Analysis - Insulin Industry Development Trend - Insulin Industry Development Proposals - Insulin New Project Investment Feasibility Analysis - Global and China Insulin Industry Research Conclusions Companies Mentioned - Bioton - Dongbao - Eli Lilly - Gan & Lee - Novo Nordisk - Sanofi - United Laboratories (TUL) For more information visit http://www.researchandmarkets.com/research/vj...al_insulin
NVO: 56.29 (+0.99), LLY: 82.09 (+0.11)
United Laboratories Inc. and Debiopharm International SA Announce the Launch of Pamorelin® LA in the Philippines
PR Newswire Europe - Mon Dec 07, 2:29AM CST
MANDALUYONG, Philippines and LAUSANNE, Switzerland, December 7, 2015 /PRNewswire/ --
Investigation Report on China's Sodium Hyaluronate Market 2015
PR Newswire Europe - Fri Sep 04, 6:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dvzsqg/investigation [http://www.researchandmarkets.com/research/dvzsqg/investigation]) has announced the addition of the "Investigation Report on China's Sodium Hyaluronate Market, 2010-2019" [http://www.researchandmarkets.com/research/dvzsqg/investigation] report to their offering.
Investigation Report on China's Sodium Hyaluronate Market, 2010-2019
M2 - Fri Sep 04, 4:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zpkc4n/investigation) has announced the addition of the "Investigation Report on China's Sodium Hyaluronate Market, 2010-2019" report to their offering. Sodium hyaluronate is a long-chain polymer containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. As a major ingredient of synovial fluid and cartilage matrix, sodium hyaluronate can lubricate the joint, protect cartilage of the joint, improve joint contracture and pathological articular fluid. Sodium hyaluronate eye drop is used for the treatment of dry eyes and mechanical lesion to corneal endothelium while sodium hyaluronate injection is used as a joint function-improving agent for intra-articular injection on osteoarthropathy patients. Currently, only sodium hyaluronate injection and eye drop are available in the market. The raw materials of sodium hyaluronate can be classified into pharmaceutical grade, external grade and edible grade. Currently, hyaluronate is mainly used as the raw material of artificial synovial fluid and eye drops after eye surgery which together brought in a global sales value of USD 700-800 million. This figure is estimated to reach up to USD 3 billion if its cosmetics are counted too. In the middle of 1990s, preparations of sodium hyaluronate began to be used in the clinic in China, achieving good efficacy in ophthalmology, orthopaedics and surgery. Sodium hyaluronate develops fast after entering China, annual sales value rising from less than CNY 100 million in 2005 to CNY 290 million in 2014 and CAGR during this period reaching 18.61%. Sodium hyaluronate enjoys a vast demand in China. Seikagaku Corporation (Japan), United Laboratories, Bausch & Lomb, Santen Pharmaceutical Co., Ltd (Japan), Shanghai Jingfeng Pharmaceutical Co., Ltd and URSAPHARM Arzneimittel GmbH Co.KG (GE) all take up certain shares in the market, among of which Seikagaku Corporation (Japan) has the largest market share of 29% for sales value in 2014. Over the last decade, the demand for sodium hyaluronate in the area of health has kept increasing. With the ever-growing demand of life quality and the rapid aging of the urban population, senile diseases like cataract and osteoarthritis, the market size of sodium hyaluronate will continue to expand in China. Companies Mentioned - United Laboratories - Bausch & Lomb - Shanghai Jingfeng Pharmaceutical Co., Ltd - Shanghai Haohai Biological Technology Co., Ltd - Santen Pharmaceutical Co., Ltd (Japan) For more information visit http://www.researchandmarkets.com/research/zp...estigation
Investigation Report on China's Adefovir Market: 2010-2014 & 2015-2019
PR Newswire Europe - Fri Aug 07, 7:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nzj6mr/investigation [http://www.researchandmarkets.com/research/nzj6mr/investigation]) has announced the addition of the "Investigation Report on China's Adefovir Market, 2010-2019" [http://www.researchandmarkets.com/research/nzj6mr/investigation] report to their offering.
GILD: 81.05 (-7.50), GSK: 44.16 (+0.12)
Azithromycin Market & Polypeptide Drug Industry - Global Research Reports
PR Newswire - Wed Apr 01, 9:00AM CDT
LifeScienceIndustryResearch.com announces 2015 Market Research Report on Global Azithromycin Industry and 2015 Deep Research Report on Global Polypeptide Drug Industry reports added to Pharmaceutical category in its database.
Hartell Announces New PlenumPlus Commercial Grade Condensate Pump at the AHR Show in Chicago
PRWeb - Mon Jan 26, 11:08AM CST
Hartell, a brand of Accudyne Industries, today announced a new version of the PlenumPlus™ Commercial Grade condensate pump that's used to remove condensate formed in venting and air ducts in the plenum spaces of office buildings, manufacturing facilities, schools, hospitals, or any other commercial space. The new condensate pump will be on display in booth #4023 at the AHR Show this week at McCormick Place in Chicago.
Global Recombinant Human Insulin Industry Report 2015
M2 - Fri Jan 09, 6:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/mmtppx/global) has announced the addition of the "Global Recombinant Human Insulin Industry Report 2015" report to their offering. The report provides an overview of the industry including definitions, classifications, applications and industry chain structure. The Recombinant Human Insulin market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Recombinant Human Insulin industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on the Recombinant Human Insulin industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Recombinant Human Insulin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Recombinant Human Insulin Industry Overview - Recombinant Human Insulin International and China Market Analysis - Recombinant Human Insulin Technical Data and Manufacturing Plants Analysis - Recombinant Human Insulin Major Countries Import Export Consumption - Recombinant Human Insulin Manufacturing Process and Cost Structure - 2009-2014 Recombinant Human Insulin Productions Supply Sales Demand Market Status and Forecast - Recombinant Human Insulin Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Recombinant Human Insulin Marketing Channels Analysis - Recombinant Human Insulin Industry Development Trend - Recombinant Human Insulin Industry Development Proposals - Recombinant Human Insulin New Project Investment Feasibility Analysis - Global and China Recombinant Human Insulin Industry Research Conclusions Companies Mentioned - Bioton - Dongbao - Eli Lilly - Novo Nordisk - United Laboratories (TUL) For more information visit http://www.researchandmarkets.com/research/mmtppx/global
NVO: 56.29 (+0.99), LLY: 82.09 (+0.11)
Trans Global Group, Inc. Develops Strategic Partnership with Arrow Electronics Inc.
ACCESSWIRE - Mon Dec 08, 7:50AM CST
CORAL SPRINGS, FL / ACCESSWIRE / December 8, 2014 / Trans Global Group, Inc. (OTC PINK: TGGI) is pleased to announce the development of a strategic partnership with Arrow Electronics, Inc. traded on the NYSE: ARW, a Fortune 150 company with sales over $21 billion for fiscal 2013.
ARW: 66.16 (+0.41)
Global Insulin Industry Report 2014
M2 - Thu Nov 27, 9:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/vjd5kp/global_insulin) has announced the addition of the "Global Insulin Industry Report 2014" report to their offering. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The insulin market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Insulin industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on seven industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The insulin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Insulin Industry Overview - Insulin International and China Market Analysis - Insulin Manufacturing Plants Capacity Analysis - Major Countries Import Export Consumption - Insulin Manufacturing Process and Cost Structure - 2009-2014 Insulin Productions Supply Sales Demand Market Status and Forecast - Insulin Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Insulin Marketing Channels Analysis - Insulin Industry Development Trend - Insulin Industry Development Proposals - Insulin New Project Investment Feasibility Analysis - Global and China Insulin Industry Research Conclusions Companies Mentioned - Bioton - Dongbao - Eli Lilly - Gan & Lee - Novo Nordisk - Sanofi - United Laboratories (TUL) For more information visit http://www.researchandmarkets.com/research/vj...al_insulin
NVO: 56.29 (+0.99), LLY: 82.09 (+0.11)
